Meet the MedCity Media Team

And take 2 minutes to help us make MedCityNews.com better for you.

Every year, we ask you to tell us a little about yourself (anonymously) to help us create better, more relevant content and features for you. We consider every response and very much appreciate you taking the time to assist us.

Please click the button above to open a simple, multiple choice survey that should only take 2 minutes to complete.

Thank you,

The MedCity Media Team

Harvard students design ChemoPatch to bring cancer treatment outside of the hospital

12:44 pm by | 0 Comments

Theratech ChemoPatchIf cancer treatment were cheaper and easier to administer, it would be more accessible to early-stage cancer patients across the world. That’s the reasoning behind a disposable, electronic chemotherapy patch designed by a bright group of undergrads at Harvard.

The students, under the company name Theratech, just won a $20,000 cash prize from the Create the Future design contest sponsored by COMSOL, Tech Briefs Media Group and SAE International.

At the core of their ChemoPatch is a plastic-based micropump that they say could automatically deliver up to three different chemotherapy drugs in select doses at specific time intervals.

Here’s how the team describes the four components of the patch in their submission:

Advertisement

1) a novel, patent-pending micropump for drug delivery
2) a drug reservoir that contains up to 3 separate chemotherapy drugs
3) a microneedle array for the painless administration of drugs
4) a simple microcontroller-based electronic circuit for complex programmable delivery scheduling

The current process for chemotherapy – delivered on a complex schedule from a pole-based IV pump – is part of what keeps it from being widely accessible for early-stage cancers, the team says. An automated, portable patch device could make it deliverable outside of the hospital setting.

Theratech says it’s planning to pilot the device, which has a production cost of $35 per unit, in early-stage breast cancer patients in India next year.

[Image credit: Theratech/Tech Briefs]

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Deanna Pogorelc

By Deanna Pogorelc MedCity News

Deanna Pogorelc is a Cleveland-based reporter who writes obsessively about life science startups across the country, looking to technology transfer offices, startup incubators and investment funds to see what’s next in healthcare. She has a bachelor’s degree in journalism from Ball State University and previously covered business and education for a northeast Indiana newspaper.
More posts by Author

0 comments